PACKAGING DESIGN ISSUE

This adverse event was reported 329 times

These drugs are most commonly taken by patients reporting PACKAGING DESIGN ISSUE:

# Drug Count
0 CYCLOSPORINE 13
1 ESTRADIOL 13
2 ESTRADIOL GEL 0.1% 7
3 ESTRADIOL TRANSDERMAL 7
4 ESTRADIOL, 7
5 ALBUTEROL SULFATE 6
6 AMINOLEVULINIC ACID HYDROCHLORIDE 6
7 LIFITEGRAST 6
8 RIBOCICLIB 6
9 APIXABAN 5
See all common drugs associated with PACKAGING DESIGN ISSUE

PACKAGING DESIGN ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) 1 1.0000
1 ANTICOAGULANT SODIUM CITRATE SOLUTION 1 0.0476
2 TRIENTINE TETRAHYDROCHLORIDE 2 0.0065
3 AMINOLEVULINIC ACID HYDROCHLORIDE 6 0.0034
4 AVACINCAPTAD PEGOL 1 0.0028
5 MITAPIVAT 3 0.0023
6 IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE 2 0.0012
7 LEVOCARNITINE 4 0.0011
8 CHLORPROMAZINE HYDROCHLORIDE 1 0.0010
9 ISOFLURANE 2 0.0010
See all drugs enriched for association with PACKAGING DESIGN ISSUE